CD276 and osteosarcoma: Immune checkpoint analysis of CD270 (HVEM), CD274 (PD-L1), and CD276 (B7H3) showed higher expression levels in metastases compared to the parental osteosarcomas, with CD274 as well as CD276 also being associated with poorer patient survival [74,75].